Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial.

Source:http://linkedlifedata.com/resource/pubmed/id/2533034

Download in:

View as

General Info

PMID
2533034